A recent study randomized non-diabetic patients with a BMI of 30 or more (n = 1961) to once-weekly subcutaneous semaglutide 2.4 mg or placebo, plus lifestyle intervention (Wilding JPH et al, N Engl J Med 2021;384(11):989)
The chart exists for a reason
To give you an idea, here are just a few of the more common, and serious, health issues that are linked to being overweight and obese: Type 2 diabetes Cardiovascular disease, including high blood pressure and heart disease Sleep apnea Arthritis Depression Fatty liver disease Gallbladder disease Fertility issues Low testosterone Sexual dysfunction If youre overweight, youre at far greater risk for developing these conditions than someone of healthy weight
In men whose endogenous GnRH/LH signalling is suppressed (for example on testosterone replacement therapy), gonadorelin can help restore that signalling pathway and maintain testicular function [5] [6]
Because of this, Novo does not believe the pill will replace injectables
- Powerful yet gentle enough for daily use